Bonumose is pleased to announce the issuance of U.S. Patent No. 11,078,506 for “Enzymatic Production of D-Allulose”.

A new Executive Director and expanded entrepreneurship program will accelerate progress for new companies.

Case Western Reserve University and Atelerix Life Sciences Inc. have signed a two-year option to license a novel family of small molecules to prevent or reverse life-threatening opioid-related side effects.

BIO-CAT Microbials, LLC is pleased to announce receipt of a “Letter of No Objection” from the United States Food and Drug Administration.

Kevin Combs is now a vital part of the rise of CVille, the life science cluster within the BHCR that is blossoming in and around the University of Virginia (UVA). 

This effort leverages CvilleBioHub’s regional ecosystem building experience, funded in part by GO Virginia, to inform the further development of four additional BioHubs.

In its history, Cav Angels – which is not formally affiliated with the University – has invested approximately $3.5 million to early-stage ventures.

With an ambitious vision for growth, advancing the organization mission, and deepening connection to the local community, CvilleBioHub announces the recent appointments of three board members to a newly expanded...

As part of the collaboration, CAV Angels will engage early in the review process with CvilleBioHub to support founders and early stage concepts to streamline the pathway for funding resources.

UVA has selected 14 promising biomedical research projects to receive funding from the Ivy Foundation COVID-19 Translational Research Fund.

This award will enable HemoShear to have more frequent interactions with the FDA, as well as eligibility for accelerated approval, priority review, and rolling submission of a new drug application.

CvilleBioHub expands its Board of Directors to align with future growth and strategic objectives.